1. Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States. (1st January 2021) Authors: Simons, Claire L.; Malone, Daniel; Wang, Michael; Maglinte, Gregory A.; Inocencio, Tim; Wade, Sally W.; Bennison, Craig; Shah, Bijal Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗